Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Clavis Pharma
Phase I * Three eligible patients will be enrolled at each dose level (DL), according to standard dose escalation decision rules * Patients will receive CP-4055 at increasing DLs until the maximum tolerated dose and the recommended dose (RD) have been established Phase II * Step 1 (The patient inclusion may stop after this step): * Patients will be enrolled at the RD until there are maximum 16 evaluable patients at this DL * Step 2: * Depending on the response rate at step 1, up to 26 patients will be included and treated at step 2
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
